Role of NF-jB activation in LPS-induced endothelial barrier breakdown

Histochemistry and Cell Biology

Volumn 138, Issue 4, 2012, Pages 627-641

  Schlegel, Nicolas ^a   Leweke, Rhea ^a   Meir, Michael ^a   Germer, Christoph Thomas ^a   Waschke, Jens ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

CAMP; Endothelial barrier; LPS; NF jB; Sepsis

Indexed keywords

CAVEOLIN; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; VASODILATOR STIMULATED PHOSPHOPROTEIN; NF KAPPA B KINASE; NF-KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENDOTHELIAL BARRIER BREAKDOWN; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; ANIMAL; CELL CULTURE; CYTOCHEMISTRY; DRUG EFFECT; ENDOTHELIUM; ENZYME ACTIVATION; GENE SILENCING; METABOLISM; PATHOLOGY; SWINE; WESTERN BLOTTING;

SUS;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM; ENZYME ACTIVATION; GENE KNOCKDOWN TECHNIQUES; HISTOCYTOCHEMISTRY; HUMANS; LIPOPOLYSACCHARIDES; PROTEIN-SERINE-THREONINE KINASES; SWINE;

EID: 84867335368     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-012-0983-7     Document Type: Article

References (44)

1. Baumer Y, Burger S, Curry FE, Golenhofen N, Drenckhahn D, Waschke J (2008) Differential role of Rho GTPases in endothelial barrier regulation dependent on endothelial cell origin. Histochem Cell Biol 129(2):179-191
2. Bogatcheva NV, Zemskova MA, Poirier C, Mirzapoiazova T, Kolosova I, Bresnick AR, Verin AD (2011) The suppression of myosin light chain (MLC) phosphorylation during the response to lipopolysaccharide (LPS): beneficial or detrimental to endothelial barrier? J Cell Physiol 226(12):3132-3146
3. Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25(6):280-288
4. Cinel I, Dellinger RP (2007) Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 20(4):345-352
5. Corsini E, Viviani B, Marinovich M, Galli CL (1997) Role of mitochondria and calcium ions in tributyltin-induced gene regulatory pathways. Toxicol Appl Pharmacol 145(1):74-81
6. Dofferhoff AS, Nijland JH, de Vries-Hospers HG, Mulder PO, Weits J, Bom VJ (1991) Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study. Scand J Infect Dis 23(6):745-754
7. Gao J, Zhao W, Zhou L, Zeng B, Yao S, Liu D, Chen Z (2006) Protective effects of propofol on lipopolysaccharide-Activated endothelial cell barrier dysfunction. Inflamm Res 55(9):385-392
8. Garrean S, Gao X-P, Brovkovych V, Shimizu J, Zhao Y-Y, Vogel SM, Malik AB (2006) Caveolin-1 regulates NF-Î kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J Immunol 177(7):4853-4860
9. Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260
10. Gong P, Angelini DJ, Yang S, Xia G, Cross AS, Mann D, Bannerman DD, Vogel SN, Goldblum SE (2008) TLR4 signaling is coupled to SRC family kinase activation, tyrosine phosphorylation of Zonula adherens proteins, and opening of the paracellular pathway in human lung microvascular endothelia. J Biol Chem 283(19):13437-13449
11. He F, Peng J, Deng XL, Yang LF, Wu LW, Zhang CL, Yin F (2011) RHOA and NF-KAPPAB are involved in lipopolysaccharideinduced brain microvascular cell line hyperpermeability. Neuroscience 11(188):35-47
12. Henes J, Schmit MA, Morote-Garcia JC, Mirakaj V, Kohler D, Glover L, Eldh T, Walter U, Karhausen J, Colgan SP, Rosenberger P (2009) Inflammation- Associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury. FASEB J 23(12):4244-4255
13. Herkenham M, Rathore P, Brown P, Listwak SJ (2011) Cautionary notes on the use of NF-jB p65 and p50 antibodies for CNS studies. J Neuroinflamm 8:141
14. Hippenstiel S, Schmeck B, Seybold J, Krüll M, Eichel-Streiber CV, Suttorp N (2002) Reduction of tumor necrosis factor-Alpha (TNF-A) related nuclear factor-kappaB (NF-jB) translocation but not inhibitor kappa-B (Ij-B)-degradation by Rho protein inhibition in human endothelial cells. Biochem Pharmacol 64(5-6):971-977
15. Irwin DC, Tissot van Patot MC, Tucker A, Bowen R (2005) Direct ANP inhibition of hypoxia-induced inflammatory pathways in pulmonary microvascular and macrovascular endothelial monolayers. Am J Physiol Lung Cell Mol Physiol 288(5):L849-L859
16. Koga S, Morris S, Ogawa S, Liao H, Bilezikian JP, Chen G, Thompson WJ, Ashikaga T, Brett J, Stern DM et al (1995) TNF modulates endothelial properties by decreasing cAMP. Am J Physiol 268(5 Pt 1):C1104-C1113
17. Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS (1999) Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 19(2):91-104
18. Kyhse-Andersen J (1984) Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 10(3-4):203-209
19. LaemmliUK(1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680-685
20. Lee WL, Slutsky AS (2010) Sepsis and endothelial permeability. N Engl J Med 363(7):689-691
21. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC, Surviving Sepsis Campaign (2010) The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 38(2):367-374
22. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev 2(10):725-734
23. Lu Y-C, Yeh W-C, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42(2):145-151
24. May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, Ghosh S (2000) Selective inhibition of NF-kappa B activation by a peptide that blocks the interaction of NEMO with the Ikappa B kinase complex. Science 289(5484):1550-1554
25. Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86(1):279-367
26. Bogatcheva NV, Zemskova MA, Kovalenkov Y, Poirier C, Verin AD (2009) Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial cells (HLMVEC) hyperpermeability. J Cell Physiol 221(3):750-759
27. Rauert H, Wicovsky A, Müller N, Siegmund D, Spindler V, Waschke J, Kneitz C, Wajant H (2010) Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2). J Biol Chem 285(10):7394-7404
28. Russell JA (2006) Management of sepsis. N Engl J Med 355(16):1699-1713
29. Sawyer SJ, Norvell SM, Ponik SM, Pavalko FM (2001) Regulation of PGE2 and PGI2 release from human umbilical vein endothelial cells by actin cytoskeleton. Am J Physiol Cell Physiol 281(3):C1038-C1045
30. Scheifele DW, Olsen EM, Pendray MR (1985) Endotoxinemia and thrombocytopenia during neonatal necrotizing enterocolitis. Am J Clin Pathol 83(2):227-229
31. Schick MA, Wunder C, Wollborn J, Roewer N, Waschke J, Germer CT, Schlegel N (2012) Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation. J Physiol [epub ahead of print]
32. Schlegel N, Baumer Y, Drenckhahn D, Waschke J (2009) Lipopolysaccharide- induced endothelial barrier breakdown is cAMP dependent in vivo and in vitro. Crit Care Med 37(5): 1735-1743
33. Schlegel N, Burger S, Golenhofen N, Walter U, Drenckhahn D, Waschke J (2008) The role of VASP in regulation of cAMP-And Rac 1-mediated endothelial barrier stabilization. Am J Physiol Cell Physiol 294(1):C178-C188
34. Schlegel N, Waschke J (2009a) Impaired cAMP and Rac 1 signaling contribute to TNF-Alpha-induced endothelial barrier breakdown in microvascular endothelium. Microcirculation 16(6):521-533
35. Schlegel N, Waschke J (2009b) Impaired integrin-mediated adhesion contributes to reduced barrier properties in VASP-deficient microvascular endothelium. J Cell Physiol 220(2):357-366
36. Schlegel N, Waschke J (2009c) VASP is involved in cAMP-mediated Rac 1 activation in microvascular endothelial cells. Am J Physiol Cell Physiol 296(3):C453-C462
37. Schlegel N, Waschke J (2010) Vasodilator-stimulated phosphoprotein: crucial for activation of Rac1 in endothelial barrier maintenance. Cardiovasc Res 87(1):1-3
38. Schnittler HJ, Wilke A, Gress T, Suttorp N, Drenckhahn D (1990) Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium. J Physiol 431:379-401
39. Spehlmann ME, Eckmann L (2009) Nuclear factor-kappa B in intestinal protection and destruction. Curr Opin Gastroenterol 25(2):92-99
40. Spindler V, Schlegel N, Waschke J (2010) Role of GTPases in control of microvascular permeability. Cardiovasc Res 87(2):243-253
41. Spindler V, Waschke J Beta-Adrenergic stimulation contributes to maintenance of endothelial barrier functions under baseline conditions. Microcirculation 18(2):118-127
42. Tiruppathi C, Shimizu J, Miyawaki-Shimizu K, Vogel SM, Bair AM, Minshall RD, Predescu D, Malik AB (2008) Role of NF-kappaBdependent caveolin-1 expression in the mechanism of increased endothelial permeability induced by lipopolysaccharide. J Biol Chem 283(7):4210-4218
43. Xing J, Birukova AA ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNF-Alpha. Microvasc Res 79(1):56-62
44. Ye X, Ding J, Zhou X, Chen G, Liu SF (2008) Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis. J Exp Med 205(6):1303-1315